Researchers at the University of Rochester Medical Center have developed a new imaging technique that could revolutionize how eye health and disease are assessed. The group is first to be able to make out individual cells at the back of the eye that are implicated in vision loss in diseases like glaucoma. They hope their new technique could prevent vision loss via earlier diagnosis and treatment for these diseases.
In a study highlighted in the Proceedings of the National Academy of Sciences, Ethan A. Rossi, Ph.D., assistant professor of Ophthalmology at the University of Pittsburgh School of Medicine, describes a new method to non-invasively image the human retina, a layer of cells at the back of the eye that are essential for vision. The group, led by David Williams, Ph.D., Dean for Research in Arts, Sciences, and Engineering and the William G. Allyn Chair for Medical Optics at the University of Rochester, was able to distinguish individual retinal ganglion cells (RGCs), which bear most of the responsibility of relaying visual information to the brain.
There has been a longstanding interest in imaging RGCs because their death causes vision loss in glaucoma, the second leading cause of acquired blindness worldwide. Despite great efforts, no one has successfully captured images of individual human RGCs, in part because they are nearly perfectly transparent.
This new approach might eventually allow us to detect the loss of single ganglion cells. The sooner we can catch the loss, the better our chances of halting disease and preventing vision loss.
Instead of imaging RGCs directly, glaucoma is currently diagnosed by assessing the thickness of the nerve fibers projecting from the RGCs to the brain. However, by the time a change is typically detected in the retinal nerve fiber thickness, a patient may have lost tens of thousands of RGCs or more.
“In principle, this new approach might eventually allow us to detect the loss of single ganglion cells,” said Williams. “The sooner we can catch the loss, the better our chances of halting disease and preventing vision loss.”
Rossi and his colleagues were able to see RGCs by modifying an existing technology – confocal adaptive optics scanning light ophthalmoscopy (AOSLO). They collected multiple images, varying the size and location of the detector they used to gather light scattered out of the retina for each image, and then combined those images. The technique, called multi-offset detection, was performed at the University of Rochester Medical Center in animals as well as volunteers with normal vision and patients with age-related macular degeneration.
While RGCs were the main focus of Rossi’s investigations, they are just one type of cell that can be imaged using this new technique. In age-related macular degeneration, cone photoreceptors that detect color and are important for central vision are the first to die. AOSLO has been used to image cones before, but these cells were difficult to see in areas near Drusen, fatty deposits that are the most common early sign of the disease. Using their multi-offset technique in age-related macular degeneration patients, Rossi was able to assess the health of cones near Drusen and in areas where the retina had been damaged.
“This technique offers the opportunity to evaluate many retinal features that have previously remained inaccessible to imaging in the living eye,” said Rossi. “Not only RGCs, but potentially other nearly transparent cell classes as well.”
Rossi and his colleagues warn that their study included a small number of volunteers and an even smaller number of age-related macular degeneration patients. More studies will be needed to improve the robustness of the technique before it can be widely used in the clinic. Rossi is now setting up his own laboratory at the University of Pittsburgh and plans to continue working with Williams’ group in studying this technique and its ability to detect changes in retinal cells over the course of retinal diseases.
Receive an email update when we add a new EYE DISEASE DETECTION article.
The Latest on: Eye disease detection
via Google News
The Latest on: Eye disease detection
- Lab-made mini brain develops its own ‘eyes’on August 19, 2021 at 3:50 am
Scientists have grown mini brains with their own sets of “eyes” that can detect light in a groundbreaking new study. “The human brain is one of the most ridiculously complex things nature has ever ...
- Tiny blobs of human brain cells are grown in a lab with rudimentary 'eyes' that can detect lighton August 18, 2021 at 8:19 am
Scientists in Germany have developed primitive 'eyes' in spherical masses of human brain tissue, known as brain organoids. The optic cups have lenses, retinas, corneas and can see light.
- AI-based eye test could help prevent severe vision losson August 17, 2021 at 3:24 am
A new artificial intelligence (AI)-based eye test can predict a condition that may develop into blindness, a recent study has determined.
- Diabetes symptoms: The early sign in your eyes not to ignore or risk blindness - studyon August 17, 2021 at 2:55 am
DIABETES will be the seventh leading cause of death worldwide by 2030, according to the World Health Organisation. The condition can affect the eyes before changes are even detectable through clinical ...
- Diabetes-Related Blindness Can Now Be Averted: Biomarkers For Detecting Early Eye Changes Identifiedon August 15, 2021 at 11:02 pm
Diabetes affects the eyes even in early stages and this is often undetected in clinical examinations. But newly identified biomarkers can help prevent this complication. TheHealthSite.com ...
- New biomarkers may detect early eye changes that can lead to diabetic retinopathyon August 15, 2021 at 10:29 am
New biomarkers found in the eyes could unlock the key to helping manage diabetic retinopathy, and perhaps even diabetes, according to new research conducted at the Indiana University School ...
- Early eye changes lead to diabetes-related blindnesson August 13, 2021 at 10:20 pm
New biomarkers found in the eyes could unlock the key to helping manage diabetic retinopathy and perhaps even diabetes according to new research conducted at ...
- New biomarkers may detect early eye changes that can lead to diabetes-related blindnesson August 13, 2021 at 12:56 pm
Researchers have identified new biomarkers that may advance the early detection of diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in U.S. adults.
- AI-supported test can predict eye disease that leads to blindnesson August 13, 2021 at 3:50 am
In a clinical trial of 113 patients led by researchers at Imperial College London and UCL, retinal imaging technology called Detection of Apoptosis in Retinal Cells (DARC) was able to identify areas ...
via Bing News